share_log

Needham Reiterates Hold on Fate Therapeutics

Moomoo 24/7 ·  Apr 11 06:09

Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:FATE) with a Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment